The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects.

MLA

Song, Ivy H., et al. “The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 72, no. 4, Aug. 2016, pp. 400–07. EBSCOhost, https://doi.org/10.1097/QAI.0000000000000983.

APA

Song, I. H., Zong, J., Borland, J., Jerva, F., Wynne, B., Zamek-Gliszczynski, M. J., Humphreys, J. E., Bowers, G. D., & Choukour, M. (2016). The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects. Journal of Acquired Immune Deficiency Syndromes (1999), 72(4), 400–407. https://doi.org/10.1097/QAI.0000000000000983

Chicago

Song, Ivy H, Jian Zong, Julie Borland, Fred Jerva, Brian Wynne, Maciej J Zamek-Gliszczynski, Joan E Humphreys, Gary D Bowers, and Mike Choukour. 2016. “The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects.” Journal of Acquired Immune Deficiency Syndromes (1999) 72 (4): 400–407. doi:10.1097/QAI.0000000000000983.